Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas
- PMID: 27593586
- PMCID: PMC5011155
- DOI: 10.1016/j.hpb.2016.06.014
Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas
Figures
References
-
- Tanaka M., Chari S., Adsay V., Fernandez-del Castillo C., Falconi M., Shimizu M. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32. - PubMed
-
- Tanaka M., Fernández-del Castillo C., Adsay V., Chari S., Falconi M., Jang J.Y. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197. - PubMed
-
- Aso T., Ohtsuka T., Matsunaga T., Kimura H., Watanabe Y., Tamura K. “High-risk stigmata” of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2014;43:1239–1243. - PubMed
-
- Goh B.K., Lin Z., Tan D.M., Thng C.H., Khor C.J., Lim T.K. Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: results from a systematic review of 1,382 surgically resected patients. Surgery. 2015;158:1192–1202. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
